• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX AFX2; BIFURCATED STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX AFX2; BIFURCATED STENT GRAFT Back to Search Results
Model Number BEA28-100/I20-40
Medical Device Problem Code Lack of Effect (4065)
Health Effect - Clinical Code Clinical Endoleak (4843)
Date of Event 05/15/2025
Type of Reportable Event Serious Injury
Event or Problem Description
The patient was treated for an abdominal aortic aneurysm (aaa) with implant of an afx2 bifurcated stent graft and an afx vela suprarenal through the right access.An angiogram showed a type iiia endoleak.The physician performed balloon touch-up from the proximal side to the distal side of the vela suprarenal but the endoleak did not disappear.The physician then elected to add a 28.5mm gore cuff (non-endologix) on the distal end of the vela suprarenal.The endoleak remained, the physician decided to monitor the patient under follow up and completed the procedure.The patient will be monitored.
 
Additional Manufacturer Narrative
The device involved in this event will not be returned for evaluation as it remains implanted in the patient.Available patient medical records and imaging studies have been received for evaluation by a clinical specialist.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.
 
Additional Manufacturer Narrative
The reported adverse event/incident was investigated in alignment with endologix operating procedures and work instructions.An evaluation of the manufacturing record was completed.A review of the part number/lot number combination needed for device identification shows the device to have been properly manufactured and released in accordance with the device master record.An evaluation of the device could not be completed.The device was not returned to endologix for evaluation because it remains implanted.A clinical evaluation of the adverse event/incident was completed.An examination of medical records and/or medical imaging received by endologix shows that the type iiia endoleak complaint is confirmed.This is consistent with the reported adverse event/incident.The type iiia endoleak is likely related to the superior stent margin of the main body being placed in a 37 degree infrarenal angle making this anatomy related.The clinical assessment determined that there was evidence to reasonable suggest a type ii endoleak occurred that was not included in the event as reported.The type ii endoleak was discovered during review of the undated angiogram movies.There was likely a contributory type ii endoleak of the lumbar artery which is also anatomy related.The complaint is most likely anatomy related.Procedure related harms could not be determined.The final patient status was reported as being monitored.No additional investigation of this reported adverse event/incident is planned.However, should additional information relevant to the investigation outcome become available, a follow-up report will be submitted.Endologix will continue to monitor this and similar adverse events/incidents.Corrections: b6: relevant tests and lab data has been updated g3: date received by manufacturer has been updated.H6: result code: remove code 3233 h6: conclusion code: remove code 11.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX2
Common Device Name
BIFURCATED STENT GRAFT
Manufacturer (Section D)
ENDOLOGIX
2 musick
irvine CA 92618
Manufacturer (Section G)
ENDOLOGIX
2 musick
irvine CA 92618
Manufacturer Contact
gary kirchgater
2 musick
irvine, CA 92618
MDR Report Key22186226
Report Number3011063223-2025-00109
Device Sequence Number8401972
Product Code MIH
UDI-Device Identifier00818009014405
UDI-Public(01)00818009014405(17)280107
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
P040002
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2025
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 05/19/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberBEA28-100/I20-40
Device Lot Number2872441001
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 05/19/2025
Supplement Date Received by Manufacturer06/24/2025
Initial Report FDA Received Date06/11/2025
Supplement Report FDA Received Date08/06/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured02/19/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
AFX VELA SUPRARENAL, LOT # 2820340014.; GORE CUFF 28.5MM (NON-ENDOLOGIX).
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-